Researcher Flouts NIH Tradition By Trying To Sit In On Review Of His Grant Proposal

An epidemiologist's move to attend a closed meeting spurs debate over freedom of information versus the right to privacy WASHINGTON--No grant applicant had ever tried to breach the sanctity of an advisory council at the National Institutes of Health--until last summer, when University of Texas epidemiologist Darwin Labarthe knocked on the door. Notwithstanding the closed-door policy of the outside panel that advises the National Heart, Lung and Blood Institute, Labarthe told the NHLBI directo

Written byDiana Morgan
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Notwithstanding the closed-door policy of the outside panel that advises the National Heart, Lung and Blood Institute, Labarthe told the NHLBI director he intended to hear for himself what this august group of scientific and community leaders thought about his research project, which they had already turned down once. And, Labarthe said, he had the law on his side.

It was the first time in the memory of anyone at the heart institute, or the NIH general counsel's office, that a scientist had attempted to attend the closed segment of one of the council's quarterly meetings. The major portion of these meetings, when general policy issues are being discussed, is open to the public. Although Labarthe ended up not attending the session, his request raised questions in the minds of institute officials about their ability to protect the privacy of the up to 300 other grant applicants whose proposals appear ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies